Delivery Order SPE2DB22D2103-SPE2DB25FR9QC
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $22,045.98 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets in quantities of 10 tablets per unit. This is a firm fixed-price delivery order with no set-aside designation, issued on September 17, 2025, with an ultimate completion date of October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $44,091.96 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a non-competitive, non-set-aside award to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SAMSCA 15 mg tablets (10 count) with a ceiling value of $10,623.60. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $10,623.60 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on August 15, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $10,623.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) with an ultimate completion date of September 15, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency awarded a $11,022.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This non-set-aside contract is scheduled for completion by June 17, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $20,539.62 contract is for the delivery of SAMSCA 15 MG TABLET 10S to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 16, 2024 and was awarded on January 26, 2024. This delivery order is issued under a larger, single-award indefinite delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Samsca 15 mg tablets (10-count packages) valued at $7,082.40 with a firm fixed price structure. The contract, which is not set-aside and was competitively awarded, requires completion by August 18, 2025, with performance to be executed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $44,091.96 to AmerisourceBergen Drug Corp for the supply of Samsca 30 mg tablets (10-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Samsca 15 mg tablets (10-count units) valued at $21,247.20 under a firm fixed-price contract type. The delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, was competitively awarded with no set-aside designation. Performance of this order will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9QCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,697.32 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets (10-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 8/4/25 |